Health Trials

Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease

ConditionAdult Congenital Heart Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLeiden University Medical Center

About this trial

This study aims to evaluate the real-world effects of cardiac resynchronization therapy (CRT) in adult patients with congenital heart disease (ACHD). Specifically, it seeks to determine whether CRT improves clinical outcomes in this unique patient population and to identify factors associated with a favorable response to therapy.

Eligibility criteria

Qualifiers

ACHD patients who underwent CRT implantation

Disqualifiers

Less than 18 years old on the moment of CRT implantation

Patient objection to the use of retrospective data

Trial design

Treatments tested in this trial

  • Cardiac resynchronization therapy

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators

Leiden University Medical Center

Lead sponsor

Source ClinicalTrials.gov